PIONEERING INNOVATION AND ADVANCING RESULTS IN R&D

Meet Anna Scribner

Unveiling Boundless Potential: Anna Scribner’s Pursuit of Excellence at Tanvex
At Tanvex, we embrace the diverse talents and expertise of our employees. In this spotlight, we delve into the journey of Anna Scribner, a remarkable member of our Research and Development (R&D) team. Anna’s passion for creating innovative solutions, her tenacity in overcoming challenges, and her commitment to translating R&D efforts into practical solutions align seamlessly with our core values. We sat down with Anna to gain insights into her motivations, collaborative prowess, and contributions to advancing pharmaceutical excellence.

Inspired by Opportunity and Alignment
Anna’s decision to join Tanvex was fueled by the unique opportunity to work closely with both the Process Development and Manufacturing teams under one roof. The prospect of gaining a holistic understanding of the biopharmaceutical industry, particularly in the realm of Purification Process Development, resonated deeply with her educational background in biological engineering. This alignment of her passions and Tanvex’s vision motivated Anna to embark on this exciting journey.

Fostering Innovation: Igniting the Spark of Creative Solutions
Within the realm of research and development, Anna finds inspiration in the pursuit of novel ideas and solutions. It is the prospect of addressing open-ended questions and overcoming complex challenges that fuels her passion. Anna thrives when given the opportunity to think outside the box, allowing her to explore uncharted territories and push the boundaries of innovation in her career. Her relentless pursuit of creative solutions drives the R&D team towards new horizons of excellence.

Collaborative Breakthroughs: Unleashing the Power of Teamwork
Anna’s teamwork skills have been instrumental in achieving breakthrough results in collaborative projects. One noteworthy collaboration involved a microbial centrifugal harvest project that brought together multiple teams, including upstream/downstream process development, MSAT, and upstream manufacturing. Effective coordination and communication were paramount, given the diverse deliverables and responsibilities of each team. Through Anna’s leadership and the team’s collective efforts, a deeper understanding of the upstream production for the product was achieved, paving the way for its final process development.

Empowerment and Creativity: Cultivating an Environment of Innovation
Anna is committed to fostering an environment of empowerment within the R&D team, where creativity and innovative thinking thrive. She actively seeks input and feedback from team members, encouraging them to contribute their ideas and perspectives. By engaging in open discussions and nurturing a collaborative atmosphere, Anna empowers her colleagues to think boldly, take ownership of their work, and drive innovation forward.

Unyielding Perseverance: Overcoming Obstacles in R&D
Anna’s tenacity has played a pivotal role in overcoming obstacles throughout her research and development endeavors. In one instance, she encountered challenges in optimizing a chromatographic operation for a purification process. Uncertainty surrounded the impact of temperature variations on the overall efficiency. Undeterred, Anna tirelessly experimented with different equipment setups until she developed a system that replicated commercial-scale conditions. Her determination allowed for crucial tests to be conducted, leading to breakthrough solutions.

Embracing Diversity for Unparalleled Innovation
Anna recognizes the value of diversity of thought and perspectives within the R&D team, as it drives innovation and fosters comprehensive problem-solving. She actively engages in discussions with colleagues, valuing their differing viewpoints and contributions. Anna’s collaborative approach cultivates an inclusive environment where everyone’s voices are heard, enabling the team to harness the power of diverse perspectives and drive meaningful advancements in pharmaceutical research.

Advancing Pharmaceutical Excellence: Anna’s Impact
Anna’s contributions to R&D have been instrumental in advancing Tanvex’s excellence in pharmaceutical products. During a manufacturing-scale development run, Anna’s meticulous approach revealed unexpected low yields in a purification operation. Through a root-cause investigation, she identified a critical process step that required optimization. By conducting a development study at the commercial scale, Anna determined the precise mixing RPM necessary to achieve optimal yield. This discovery not only improved the purification process for the specific pharmaceutical but also paved the way for enhanced efficiency and product quality across the board.

Aligning Innovation with Patient Benefits and Core Values
Anna ensures that her work in R&D translates into practical solutions that benefit patients and align with Tanvex’s core values. By meticulously conducting process development, Anna sets the foundation for a seamless transition to GMP manufacturing. Her commitment to efficiency and accuracy ensures the production of well-made pharmaceuticals that positively impact patient lives, upholding Tanvex’s unwavering dedication to excellence and patient-centricity.

Anna Scribner’s journey in Tanvex’s R&D team exemplifies the unwavering commitment to innovation, collaboration, and excellence that defines our organization. Her passion for creative problem-solving, tenacity in overcoming challenges, and commitment to patient well-being drive our pursuit of pharmaceutical excellence.